Low-/high-dose-rate brachytherapy boost in patients with intermediate-risk prostate cancer treated with radiotherapy: long-term results from a single institution team experience.
J Contemp Brachytherapy
; 13(2): 135-144, 2021 Apr.
Article
in En
| MEDLINE
| ID: mdl-33897786
Full text:
1
Database:
MEDLINE
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Year:
2021
Type:
Article